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ABSTRACT
The proximal 5’-flanking region of the human
platelet-derived growth factor A (PDGF-A) promoter
contains one nuclease hypersensitive element (NHE)
that is critical for PDGF-A gene transcription. On the
basis of circular dichroism (CD) and electrophoretic
mobility shift assay (EMSA), we have shown that the
guanine-rich (G-rich) strand of the DNA in this region
can form stable intramolecular parallel G-quadru-
plexes under physiological conditions. A Taq poly-
merase stop assay has shown that the G-rich strand
of the NHE can form two major G-quadruplex
structures, which are in dynamic equilibrium and
differentially stabilized by three G-quadruplex-inter-
active drugs. One major parallel G-quadruplex
structure of the G-rich strand DNA of NHE was
identified by CD and dimethyl sulfate (DMS) foot-
printing. Surprisingly, CD spectroscopy shows a
stable parallel G-quadruplex structure formed within
the duplex DNA of the NHE at temperatures up to
100uC. This structure has been characterized by
DMS footprinting in the double-stranded DNA of the
NHE. In transfection experiments, 10kM TMPyP4
reduced the activity of the basal promoter of PDGF-
A »40%, relative to the control. On the basis of these
results, we have established that ligand-mediated
stabilization of G-quadruplex structures within the
PDGF-A NHE can silence PDGF-A expression.
INTRODUCTION
Platelet-derived growth factor (PDGF), which was
originally isolated from human platelets, is composed
of four polypeptide chains designated A, B, C and D.
These polypeptide chains make up ﬁve biologically active
dimeric PDGF isoforms: PDGF-AA, -AB, -BB, -CC and
-DD, which exert their eﬀects through two tyrosine kinase
receptors, PDGFR-a and PDGFR-b (1–3). PDGF-A and
PDGF-B are considered to be major mitogens for a
variety of mesenchymal cell types. They play critical roles
in normal embryonic development, cellular diﬀerentiation
and wound healing (1–4). The overactivity of the PDGFs
has been implicated in the pathogenesis of a number of
diseases characterized by excessive cell growth, including
cancer, atherosclerosis and various ﬁbrotic conditions
(3,5,6). Signiﬁcantly augmented expression of the
PDGF-A gene has been observed in a number of human
tumor cell lines and tissues, particularly in gliomas,
sarcomas and ostoastrocytomas (6–10). Abnormal
PDGF-A expression is linked to accelerated malignant
cell growth through autocrine and paracrine pathways
(1,6,11). For these reasons, PDGF signaling pathways are
important targets for anticancer therapeutics; speciﬁcally,
inhibitors of PDGF-A gene expression could be valuable
in the treatment of some cancers.
Transcription of the PDGF-A gene is controlled by
several positive and negative regulatory elements located
in the promoter region and the 50-distal upstream region
of the gene (Figure 1) (12–14). An important, highly
guanine- and cytosine-rich region located at nucleotides
–120 to –33 within the PDGF-A promoter accounts for
80% of basal promoter activity. This GC-rich region was
originally identiﬁed by its sensitivity to the single-strand-
speciﬁc endonuclease S1 nuclease and has been termed the
nuclease hypersensitive element (NHE) (12–14). PDGF-A
is also subject to transcriptional repression by two discrete
S1 nuclease hypersensitive (SHS) elements. One is located
within the 50-distal region (–1418 to –1338) of the
promoter (50SHS), while the other is located within the
ﬁrst intron (+1605 to +1630, intron SHS) (14–17).
Multiple transcription factors bind to and regulate
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Egr-1, Wilms’ tumor protein (WT1), GC factor 2 (GCF2),
nuclear factor 1-X (NF1-X) and the metastasis suppressor
protein NM23 (17–23). This region is structurally dynamic
and capable of adopting non-B-DNA conformations (24).
The importance of the unwound paranemic structure of
NHE in PDGF-A promoter activity was conﬁrmed by
demonstrating that a single-stranded DNA oligomer,
derived from the guanine-rich strand (–74 to –51), inhibits
the promoter activity of PDGF-A (24). It is believed that
the equilibrium between the B-form DNA, the single-
stranded DNA, and intramolecular secondary DNA
structures is instrumental in the determination of the
binding of transcription factors to the NHE region of
PDGF-A (NHEPDGF-A). However, the molecular details
of the unwinding of secondary structures in the
NHEPDGF-A are poorly understood.
Tandem repeats of the guanine-tract (G-tract) sequence
adopt speciﬁc intramolecular G-quadruplex structures in
the telomeres and promoters of several important genes,
such as c-MYC, KRAS, Bcl-2, c-Kit and VEGF (25–29).
The basic building block, the G-tetrad, and examples of
folding patterns are shown in Figure 1B. The involvement
of G-quadruplex structures in cellular processes, such
as transcriptional control of c-MYC expression, has
stimulated the development of anticancer drugs that
are selective for G-quadruplexes. The G-rich strand of
NHEPDGF-A contains ﬁve contiguous guanine runs,
each separated by one base. The G-tract motif in
NHEPDGF-A has some similarity to the G-tract motif
in the NHE region of c-MYC (NHEc-MYC). However,
in NHEc-MYC the minimum number of guanines in any
run is three rather than four, and NHEPDGF-A contains a
very long run of 13 contiguous guanines at the 50-end
(see sequences in Figure 2A) (25,30). Since the G-rich
strand of NHEc-MYC is known to form G-quadruplex
structures, by analogy the G-rich strand of NHEPDGF-A
has the potential to form G-quadruplex structures
under physiological conditions. Consequently, these
G-quadruplex structures may play an important role in
modulating the expression of PDGF-A. For these reasons,
this work examines the in vitro formation and properties
of G-quadruplex structures within the G-rich strand of
NHEPDGF-A, including its transcriptional modulation by
TMPyP4.
MATERIALS AND METHODS
Oligodeoxynucleotides, enzymes, materials anddrugs
DNA oligomers (sequences shown in Table 1) were
obtained from Sigma Genosys and Biosearch Techno-
logies, Inc. All DNA oligomers were PAGE-puriﬁed and
dissolved in double-distilled water before use. The
extinction coeﬃcients that the manufacturers provided
for a given DNA sequence were calculated using the
nearest-neighbor method (31). When the DNA oligomers
fold into a G-quadruplex, the base stacking results in
hyperchromicity. Thus, the extinction coeﬃcients of DNA
oligomers that can form DNA secondary structures need
to be corrected for the hyperchromicity. To address this
issue, we used UV/vis thermal denaturation techniques to
determine the high-order structural hyperchromicity of
the G-quadruplex-forming DNA oligomers (32). The UV
experiments were carried out on a Cary 300 Bio
UV-visible spectrophotometer. Cells with optical path
lengths of 10mm were used, and the temperature of the
cell holder was controlled by an external circulating water
bath (Varian). The UV melting experiments were done by
collecting spectra every ﬁve degrees as the sample heated
up from 20 to 1008C, and monitoring the absorption
change at max. The plateau at the top of the melting curve
Figure 1. (A) Promoter structure of PDGF-A and locations of the important NHEs. The sequences of the 50SHS, the G-rich strand of the NHE and
the intron SHS are shown. TSS=transcriptional start site. (B) Structure of a G-tetrad and examples of the folding patterns of known intramolecular
G-quadruplexes.
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back to 208C to obtain the hyperchromicity. The
extinction coeﬃcient for the G-quadruplex-forming
DNA oligomer was corrected by using the following
equation: “260(Q)=“260(N)/(1+(%hyperchromicity/
100)). “260(Q) represents the extinction coeﬃcient for the
G-quadruplex-forming DNA oligomer, and “260(N)
represents the extinction coeﬃcient for the non-structured
single-stranded DNA oligomers. The corrected “260(Q)
values for select DNA oligomers in our study are as
























(29:1) solution and ammonium persulfate were purchased
from Bio-Rad, and N,N,N0,N0-tetramethylethylenedia-
mine was purchased from Fisher. T4 polynucleotide
kinase and Taq DNA polymerase were purchased from
Promega. [g-
32P]ATP was purchased from NEN Dupont.
TMPyP2, TMPyP4 and Se2SAP were synthesized in our
laboratory. Telomestatin was kindly provided by
Dr Kazuo Shin-ya (University of Tokyo, Japan). Stock
solutions of telomestatin and Se2SAP (10mM) were
made using DMSO (10%) and double-distilled water,
Figure 2. (A) Comparative CD spectra of three known G-quadruplex-forming sequences with the PDGF-A Pu48-mer. Blue line=PDGF-A Pu48-
mer (25mM KCl), red line=c-Myc Pu27-mer (parallel G-quadruplex in 25mM KCl), green line=Bcl-2 Pu39WT (mixed parallel/antiparallel
G-quadruplex in 100mM KCl), black line=TBA (antiparallel G-quadruplex in 100mM KCl). All CD data were obtained with a 5mM strand
concentration at 258C. Comparison of sequences of these two DNA oligomers is shown under the CD spectra. (B) Native gel electrophoresis
indicating the formation of intramolecular G-quadruplex structures by Pu48-mer. The fast mobility major band represents the intramolecular
G-quadruplex and the slow mobility bands represent the higher-order intermolecular G-quadruplexes. (C) Eﬀect of alkali metals on the Pu48-mer
CD spectra. Eﬀect of KCl (red line) and NaCl (blue line) on the ellipticity signal compared to the signal in the absence of salt (black line). All CD
data were obtained with a 5mM strand concentration at 258C.
7700 Nucleic Acids Research, 2007, Vol. 35, No. 22respectively. Further dilutions to working concentrations
were made with double-distilled water immediately prior
to use. Plasmid pGL3-basic, pRL-TK and dual luciferase
assay kits were purchased from Promega.
Circular dichroism spectroscopy
CD spectra were recorded on a Jasco-810 spectropolari-
meter (Easton, MD, USA) using a quartz cell of 1mm
optical path length and an instrument scanning speed of
100nm/min, with a response time of 1s, over a wavelength
range of 200–330nm. All DNA samples were dissolved
and diluted in Tris–HCl buﬀer (50mM, pH 7.6), and
where appropriate, the samples also contained diﬀerent
concentrations of KCl and/or NaCl. The DNA strand
concentrations were 5mM, and the CD data represent
four averaged scans taken at an experimental temperature
(25–1108C). All CD spectra are baseline-corrected for
signal contributions due to the buﬀer.
Labeling and purification ofoligodeoxyribonucleotides
The DNA oligomers were 50-end-labeled with [g-
32P]ATP
using T4 polynucleotide kinase for 1h at 378C. The
labeling reaction was inactivated by heating the samples at
908C for 8min after the addition of 1.5ml of 0.5M EDTA.
The 50-end labeled DNA was then puriﬁed using a Bio-
Spin 6 chromatography column (Bio-Rad). The labeled
DNA was further puriﬁed by running a 12% denatured
polyacrylamide gel that contained 8.0M urea.
Preparation ofintramolecular G-quadruplexstructures by
EMSA
The 50-end
32P-labeled single-stranded DNA oligomer was
incubated in Tris–HCl buﬀer (50mM, pH 7.6) containing
diﬀerent concentrations of KCl and/or NaCl for 1h at
room temperature. The denatured marker DNA oligomers
were prepared separately before the EMSA. The control
DNA oligomers were heated at 958C for 15min. They
were then immediately put on ice and cooled to 48C before
loading the gel. The secondary structures of the DNA
oligomers were obtained by heating the stock solutions at
908C for 10min and then slowly cooling to room
temperature over 4h. The monomolecular G-quadruplex
structure of the G-rich strand of the NHE was isolated by
non-denatured gel electrophoresis in the presence of
10mM NaCl and KCl in Tris-Borate-EDTA buﬀer.
Electrophoresis of the DNA was conducted at 150V.
The diﬀerent mobility shift DNA bands were cut from the
non-denatured gel and soaked in double-distilled water.
The double-stranded 60-mer NHE was obtained ﬁrst by
annealing equal amounts of 60-mer G-rich strand (Pu60-
mer, 50-end
32P-labeled) and C-rich strand (Py60-mer) in
annealing buﬀer (10mM Tris–HCl, pH 7.5, 10mM NaCl),
heating the mixtures at 758C for 15min, and then slowly
cooling the DNA sample to room temperature. The major
double-stranded DNA band was isolated from a 12%
native polyacrylamide gel. For inducing the formation of
G-quadruplexes in the duplex DNA, the double-stranded
60-mer NHE was incubated in diﬀerent concentrations of
KCl buﬀers at room temperature for at least 1h, then
heated at 658C and allowed to slowly cool to room
temperature over 4h.
Taq polymerase stopassay
The DNA primer 50-d(TCGACTCTAAGCAAATGCGT
CGAG)-30 was 50-end-labeled with
32P as described above.
The labeled primer was annealed to the DNA template
(sequence shown in Table 1) by using the aforementioned
protocol. The DNA complex formed by annealing the
primer to the template was puriﬁed using gel electrophore-
sis on a 12% native polyacrylamide gel. The puriﬁed DNA
was then diluted to a concentration of 0.2nM and mixed
with the reaction buﬀer (10mM MgCl2, 0.5mM DTT,
0.1mM EDTA, 1.5mg/ml BSA) and 0.1mM dNTPs.
Where appropriate, KCl, NaCl and/or drugs were also
added. The reaction mixtures were incubated for 1h at
room temperature, allowing the alkali metal ions or drugs
to stabilize the G-quadruplexes. Taq DNA polymerase
was then added, and samples were incubated for 30min
at 608C for polymerase extension. The polymerase
extension reaction was stopped by adding 2  stop buﬀer
(10mM EDTA, 10mM NaOH, 0.1% xylene cyanole,
0.1% bromophenol blue in formamide solution), and
the samples were analyzed on a 16% denatured poly-
acrylamide gel (33).
DMSfootprinting
Each band of interest was excised from the EMSA and
soaked in 1  Tris-Borate-EDTA buﬀer containing 10mM
Table 1. Oligodeoxynucleotides used in this study
DNA oligomer Sequence (50 !30)
PDGF-A Pu48 GGAGGC GGGGG GGGGG GGGCG GGGGC
GGGGG CGGGG GAGGG GCGCG GC
PDGF-A Pu60 CCGGG GAGGC GGGGG GGGGG GGGCG
GGGGC GGGGG CGGGG GAGGG GCGCG
GCGGC GGCGG
PDGF-A Py60 CCGCC GCCGC CGCGC CCCTC CCCCG
CCCCC GCCCC CGCCC CCCCC CCCCC
GCCTC CCCGG
PDGF-A Pu90 TGCGG GTCCC AGGCC CGGAA TCCGG
GGAGG CGGGG GGGGG GGGGC GGGGG
CGGGG GCGGG GGAGG GGCGC GGCGG
CGGCG GCTAT AACCC
Template
a CGGG GAGGC GGGGG GGGGG GGGCG
GGGGC GGGGG CGGGG GAGGG GCGCG
GTTAG TCAGA CCTCG ACGCA TTTGC
TTAGA GTCGA
Primer
b TCGAC TCTAA GCAAA TGCGT CGAG
c-MYC Pu27 TGGGG AGGGT GGGGA GGGT GGGG AAGG
TBA GGTT GGTG TGGTT GG
Bcl-2 Pu39WT AGGGG CGGGCG C GGG AGGAA GGGGG
CGGGAG C GGGG CTG
PA-5W AGGC GGGGG GGGGG GGGCG GGGGC
GGGGG CGG
PA-Mut1 AGGC GGGGG GGGGG GGGCT GGGGC
TGGGG CGG
PA-Mut2 AGGC GGGGG GGGGG GGGCA GGGGC
AGGGG CGG
aTemplate used in Taq DNA polymerase stop assay.
bPrimer used in Taq DNA polymerase stop assay.
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at room temperature for 3h in water. The solutions
were ﬁltered and 50000c.p.m. per reaction of DNA
solution was further diluted with 0.1  TE (10mM Tris,
1mM EDTA, pH 7.5) to a total volume of 90ml per
reaction. Following the addition of 1ml calf thymus DNA
(0.1mg/ml), the reaction mixture was incubated with 1mlo f
25% dimethyl sulfate solution (DMS:ethanol; 1:4, vol/vol)
for 5 or 10min. Each reaction was stopped by adding 18ml
of stop buﬀer (3M b-mercaptoethanol:water:NaOAc;
1:6:7, vol/vol). After ethanol precipitation and washing,
the piperidine cleavage reaction was performed by
heating the samples to 908C for 30min in 30ml piperidine.
The samples were separated on a 20% denatured
polyacrylamide gel and visualized on a phosphorimager
(Storm 820). DMS analysis of random unstructured
control DNA oligomer was performed in the same
way by using heat-denatured (quick cooling on ice)
50-end-labeled oligomer (25).
Imagingand quantitation
The dried gel was exposed on a phosphor screen. Imaging
and quantitation were performed using a phosphorimager
(Storm 820) and ImageQuant 5.1 software from
Amersham Biosciences.
Plasmid construction
The DNA sequence of the –222 to +119 region of the
PDGF-A promoter, relative to the transcriptional start site
(12,13), was obtained by PCR-amplifying human genome
DNA extracted from HPDE-6 cells with the primer pair
(50-GGGGCTTTGATGGATTTAGC-30 and 50-CCTGA
GGGCGGCGCAAGGCCG-30). This fragment was sub-
cloned into the multiple cloning sites region, between
HindIII and ScaI, of the pGL3-basic vector (Promega),
which is a promoter-less plasmid containing the ﬁreﬂy
luciferase reporter gene. The resultant clone pA361 was
characterized by DNA sequencing, and the correct
orientation of the insert was veriﬁed by restriction
enzyme analysis.
Cellculture, transient transfection and dualluciferase assay
Human pancreatic cancer MIA PaCa-2 cells were cultured
in Dulbecco’s Modiﬁed Eagle’s Medium, containing
100 U/ml penicillin, 100mg/ml streptomycin, 200mM
L-glutamine and 10% FBS (Mediated Inc.). Cells were
maintained in a logarithmic phase of growth. For
transfection experiments, cells were seeded in 6-well
dishes with a concentration of 2 10
5 cells per well and
treated with varying concentrations of TMPyP4 or
TMPyP2 (up to 50mM). Each well was co-transfected
with 2mg of pA361 and 25ng of pRL-TK with
TransFectin (BioRad). pRL-TK (Promega), containing a
renilla luciferase gene driven by the herpes simplex virus
thymidine kinase promoter, was used as a control for
transfection eﬃciency. The expression of ﬁreﬂy luciferase,
with respect to that of renilla luciferase, was determined
by dual luciferase assay (Promega), 24h after transfection
(as described by the manufacturer). Cell lysate (20ml) was
mixed with 100ml of reconstituted luciferase assay reagent,
and light output was measured for 12s with a FB12
Luminometer (Berthold).
RESULTS
The G-rich strand of thePDGF-A NHE forms
intramolecular G-quadruplexstructures
Since signature CD spectra have been determined for
several well-deﬁned G-quadruplex structures in solution,
comparative CD analysis can provide primary evidence
for the existence of G-quadruplex structures in an
unknown DNA sequence and also provide insight into
the topology of G-quadruplexes (34–44). To determine
the potential presence of G-quadruplex structures
within the G-rich strand of NHEPDGF-A, we used CD to
analyze the purine strand Pu48-mer, which represents the
whole core sequence of the G-rich strand of NHEPDGF-A
(–40 to –87 in the PDGF-A promoter). Figure 2A (blue
line) shows that Pu48-mer exhibited a CD spectrum
characterized by a maximum positive ellipticity at 266nm,
a negative band at 240nm and a minor positive band at
212nm. This spectrum is similar to that of the guanine-
rich DNA oligomer Pu27-mer of NHEc-MYC (red line
in Figure 2A), which forms intramolecular parallel
G-quadruplex structures that have been well characterized
by NMR, CD and DMS footprinting studies (29,38,45).
To further identify the topology of the G-quadruplex
structures formed in Pu48-mer, we compared the CD
spectrum of Pu48-mer to two other DNA sequences, the
thrombin binding aptamer (TBA) (black line in
Figure 2A) and the Bcl-2 Pu39WT (green line in
Figure 2A). The chair-type antiparallel G-quadruplex
structure of TBA has been proposed on the basis of NMR
and X-ray crystallography (46), and it has a signature
CD spectrum characterized by a positive maximum
band around 290nm, a negative band at 265nm and
a smaller positive band at 246nm. The hybrid parallel/
antiparallel G-quadruplex structure of Bcl-2 Pu39WT was
solved by NMR (47). The CD spectrum of this hybrid
G-quadruplex structure shows a major positive band at
 265nm with a negative band at 240nm, which is similar
to the parallel G-quadruplex. However, it has a unique
pronounced shoulder absorption between 280 and
300nm, which is not observed in the CD spectrum of
the parallel G-quadruplex (27). The CD spectrum of the
Pu48-mer is quite diﬀerent from those of Bcl-2 Pu39WT
and TBA, and it resembles most closely that of the c-MYC
Pu27-mer. Collectively, these data suggest that the major
G-quadruplex structure in the Pu48-mer is a parallel
structure.
DNA oligomers folding into intramolecular
G-quadruplex structures migrate faster than non-
structured single-stranded DNA and the corresponding
intermolecular dimers in a native gel (48,49). Thus, it is
possible to isolate the intramolecular G-quadruplex
structure from the other DNA structures by native
gel electrophoresis. To determine whether the
G-quadruplexes formed by Pu48-mer in our CD studies
are intra- or intermolecular, we analyzed the electro-
phoretic mobilities of diﬀerent concentrations of
7702 Nucleic Acids Research, 2007, Vol. 35, No. 22Pu48-mer in the presence of 50mM KCl. When the DNA
concentration was 15mM or lower (Figure 2B, lanes 2–4),
the major DNA species of Pu48-mer migrated in an 8%
native polyacrylamide gel much faster than the corre-
sponding denatured Pu48-mer that represents the random
linear DNA structure (Figure 2B, lane 1 as control).
These results suggest that the Pu48-mer folds into a
compact intramolecular G-quadruplex at low DNA
concentrations. However, when the DNA concentration
was 20mM, more than 40% of the Pu48-mer was found as
a slowly migrating species, which is presumed to represent
higher-order intermolecular DNA complexes (Figure 2B,
lane 5). Since the concentration of the DNA oligomer
used in our CD studies is 5mM, it is reasonable to assume
that the G-quadruplexes formed in these conditions are
intramolecular.
K
+ facilitates the formationof intramolecular
G-quadruplexes in theG-rich strandof NHEPDGF-A
To examine the eﬀects of the alkali metal ions (K
+ and
Na
+) on the formation of G-quadruplexes in the G-rich
strand of NHEPDGF-A, we monitored the CD spectra of
Pu48-mer in the presence of either 100mM KCl or
100mM NaCl. These CD spectra showed similar parallel
G-quadruplex characteristics. However, a dramatic
increase in the elliptic intensity was observed with the
sample that was pre-incubated with 100mM KCl
(Figure 3A, red line), while 100mM NaCl only slightly
increased the magnitude of the CD signal around
280–300nm (Figure 2C, blue line) as compared to the
spectrum of DNA in the Tris–HCl buﬀer alone
(Figure 2C, black line). This indicates that K
+ or Na
+
can increase the formation of the PDGF-A Pu48-mer
G-quadruplex, but a more signiﬁcant eﬀect occurs with
K
+.K
+ strongly increases the formation of the parallel
Pu48-mer G-quadruplex structure, while Na
+ appears to
induce the formation of a hybrid parallel/antiparallel
Pu48-mer G-quadruplex structure. Further evidence that
K
+ stabilizes the Pu48-mer G-quadruplex structure was
obtained by comparing the melting curve of Pu48-mer in
the absence or presence of KCl. We monitored the CD
spectra of Pu48-mer as a function of temperature and then
plotted the ellipticity at 266nm versus temperature to
generate a melting curve. The full melting curve of Pu48-
mer in Tris–HCl (50mM, pH 7.2) showed a Tm of 758C
(data not shown). This high Tm suggests that intramole-
cular Pu48-mer G-quadruplex structures are very stable.
Surprisingly, in the presence of 25mM KCl, the Pu48-mer
still showed a detectable parallel G-quadruplex CD signal
at 1108C. Because of the high-temperature limit of our CD
instrument, we could not obtain a full melting curve for
the Pu48-mer in 25mM KCl. This result implies that K
+
can signiﬁcantly stabilize the Pu48-mer G-quadruplex and
increase its Tm.
Figure 3. Eﬀect of K
+ and Na
+ on the formation of the NHEPDGF-A G-quadruplex in a Taq polymerase stop assay. Two stop products are
designated as the 50-end product and the 30-end stop product. The corresponding arrest sites are indicated on the core G-tract sequence.
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+ on the formation of
G-quadruplexes in the NHEPDGF-A was conﬁrmed by Taq
polymerase stop assay. This assay is a useful tool to
investigate the capability of G-rich DNA sequences to
form stable G-quadruplex structures in vitro, based on the
assumption that a stable DNA secondary structure in
the DNA template is able to stop primer extension by the
DNA polymerase (33). A cassette template DNA contain-
ing the Pu48-mer of NHEPDGF-A was annealed with a
labeled primer, which subsequently was extended with Taq
polymerase in the presence of increasing concentrations of
KCl or NaCl. A full-length product was synthesized in the
presence of NaCl (Figure 3, lanes 3–5); however, upon
replacement of NaCl by KCl to the reaction, two major
premature primer extension products were produced and
designated as the 50-end stop product and the 30-end stop
product (Figure 3, lanes 7–9). Both of these arrest
products increased in a K
+-dependent manner but were
not aﬀected by Na
+. Thus, the K
+-speciﬁc block to DNA
synthesis is not due to general eﬀects of alkali ions.
Collectively, these results suggest that the G-rich strand of
NHEPDGF-A has the capacity to form two separate
intramolecular parallel G-quadruplex structures that are
preferentially stabilized by K
+.
Formation of multiple G-quadruplex structures in
the G-rich strand ofNHEPDGF-A
The G-rich strand of NHEPDGF-A is composed of ﬁve
G-tracts and has the potential to form multiple
G-quadruplexes structures, based on the assumption that
each G-tract has an equal possibility of participating in
the formation of G-quadruplexes. The Taq polymerase
stop assay in Figure 3 showed that two signiﬁcant stop
products are formed within the NHEPDGF-A. This
indicates that at least two major, stable intramolecular
G-quadruplex structures are formed by diﬀerent G-tracts
in the G-rich strand of NHEPDGF-A. The Taq polymerase
arrest sites for these two major stop products were
determined by sequencing the template DNA. The
arrested site for the 30-end stop product corresponded to
G41 in the PDGF-A Pu48-mer (core sequence of
NHEPDGF-A, as shown under the gel in Figure 3). The
arrest product at G41 suggest that bases G37–G41 must
form a stable cap structure on the 30-end of the
G-quadruplex. The arrested site for the 50-end stop
product corresponded to G25 in the Pu48-mer
(Figure 3). This indicates that the three consecutive runs
of guanines at the 50-end of Pu48-mer (G1–G25) form
the G-quadruplex structure of the 50-end stop product.
Figure 4. The EMSA (A) and DMS footprinting (B) of intramolecular G-quadruplex structures of PDGF-A Pu48-mer. In (A), high-mobility bands 1
and 2 represent compact intramolecular G-quadruplex structures, and band 3 represents linear DNA, which was fully denatured by heating. In (B),
DMS footprinting of band 1 (lanes 1 and 2), band 2 (lanes 4 and 5) and band 3 (lane 3) from (A) is shown. Open circles indicate the guanines that
are fully protected, partially open circles indicate the guanines that are partially protected and arrowheads indicate the guanines that are cleaved.
7704 Nucleic Acids Research, 2007, Vol. 35, No. 22One structural characteristic of particular interest is
that the 13-mer G-tract must provide the two runs
of presumably four guanines at the 50-end of the
G-quadruplex.
Native polyacrylamide gel electrophoresis of Pu48-mer,
which was pre-incubated with 100mM KCl, shows
two fast migrating bands (Figure 4A, bands 1 and 2)
that move faster than the denatured unstructured linear
DNA species (band 3). These high-mobility species
are presumed to represent compact intramolecular
G-quadruplex structures. The close mobility and
broadness of two intramolecular G-quadruplexes
(bands 1 and 2) indicate that the Pu48-mer may
form multiple similarly structured intramolecular
G-quadruplexes.
To further probe the structures of the two intramolec-
ular G-quadruplexes, a DMS footprinting experiment
was carried out. Since N7 of guanine in a G-tetrad is
involved in Hoogsteen bonding and is inaccessible to
alkylation by DMS, we can identify those guanine bases
engaged in the formation of a G-quadruplex structure.
The DMS methylation pattern produced by band 3 was
consistent with a linear single-stranded DNA (Figure 4B,
lane 3). For bands 1 and 2 (Figure 4B, lanes 1 and 2 and
lanes 3 and 4), the DMS protection patterns suggested the
formation of intramolecular G-quadruplexes. As shown in
Figure 4B (lanes 1 and 2), full DMS protection occurred
within the four runs of guanines (G3–G4, G8–G10, G16–
G19 and G22–G25) of band 1. For band 1, the DMS
protection of the two four-guanine G-tracts (G16–G19,
Figure 5. (A) Eﬀect of temperature (25–1008C) on the CD spectra of 90bp duplex DNA containing NHEPDGF-A. At 1008C, 90bp duplex DNA of
NHEPDGF-A still generated a strong G-quadruplex CD signal. (B) Non-denatured gel analysis of 60-mer G-rich single-stranded DNA of NHEPDGF-A
(lane 1) and 60bp double-stranded DNA of NHEPDGF-A (lanes 2 and 3). In lanes 1 and 2, the G-rich strand was 50-end-radiolabeled with
32P, and
the C-rich strand was 50-end-radiolabeled with
32P in lane 3. (C) DMS footprinting for G-rich strands of 60bp duplex DNA band 1 (lanes 1 and 2)
and band 2 (lanes 3 and 4). Lane 5 shows the CT sequencing on the G-rich strand of the 60bp duplex DNA of NHEPDGF-A. Open circles indicate the
guanines that are fully protected, partially open circles indicate the guanines that are partially protected, and arrowheads indicate the guanines that
are cleaved.
Nucleic Acids Research, 2007, Vol. 35, No. 22 7705G22–G25) at the 30-end of the NHEPDGF-A is clear, while
the remaining two G-tracts within the run of 13 guanines
at the 50-end of the NHEPDGF-A are less well deﬁned.
Within the long run of 13 guanines there are two runs of
guanines that are clearly protected: a run of two guanines
(G3–G4) and three guanines (G8–G10). Partial protection
of the intervening run of guanines (G5 and G7) occurs
between these two fully protected regions, and likewise
G11 is partially protected. The ﬁrst guanine involved in
the formation of the G-tetrad at the 30-end of band 1 is
G25. This corresponds to the arrest site for the 50-end stop
product in the Taq polymerase stop assay (Figure 3). For
band 2 (lanes 4 and 5), most guanines within the two
50-runs of guanine (G1–G13 and G15–G19), with the
exception of G1 and G2, were partially protected from
DMS methylation, with only two runs of guanines (G22–
G25 and G27–G30) showed full protection (Figure 4B,
lanes 4 and 5). These somewhat ill-deﬁned N7 methylation
protection patterns do not provide straightforward insight
into the speciﬁc G-quadruplex structures for the DNA
species in bands 1 and 2. Most probably these ill-deﬁned
bands result from mixtures of multiple intramolecular
G-quadruplexes existing in dynamic equilibrium (see
Discussion Section).
Formation of a G-quadruplex within the double-stranded
DNA of NHEPDGF-A. To date, all well-characterized
G-quadruplex structures have been determined by study-
ing single-stranded DNA in vitro (25–30,35,36,41,42). To
investigate the potential for G-quadruplex formation
within the duplex DNA of NHEPDGF-A, we used CD to
study a 90 base pair duplex DNA, derived from the –24 to
–113 region of the PDGF-A promoter, that contained
about 20 base pairs ﬂanking each side of the NHE core
sequence. Signiﬁcantly, the CD spectrum of the NHE
90bp double-stranded DNA exhibited an almost identical
CD spectrum to the parallel G-quadruplex formed in the
single-stranded DNA (Figure 2A, blue line), which is
characterized by a positive ellipticity maximum at 266nm
and a negative minimum at 240nm (Figure 5A). This CD
spectrum is substantially diﬀerent from the CD signal
of B-form duplex DNA, which typically has an ellipticity
maximum absorption around 275–280nm and zero
ellipticity at 258nm. In addition, the CD bands of
B-form DNA are much weaker (34,50,51). This CD
proﬁle of the NHE 90bp double-stranded DNA indicates
that a dominant intramolecular parallel G-quadruplex is
formed within the duplex DNA of NHEPDGF-A.T o
determine the stability of this G-quadruplex structure,
we monitored the CD spectra of the NHE 90bp double-
stranded DNA over a 25–1008C temperature range.
Notably, the DNA sample still generated very strong
parallel G-quadruplex CD signals, even above 1008C
(Figure 5A). This indicates that the G-quadruplex
structure formed in the NHE duplex DNA is very stable.
To identify the G-quadruplex structure formed in the
NHE duplex DNA, a 60bp double-stranded DNA of
NHE (–33 to –92 in the PDGF-A promoter), which was
shown to have better resolution for DMS footprinting
than the 90bp double-stranded DNA, was used. The CD
spectrum of puriﬁed NHE 60-mer double-stranded DNA
was consistent with that of the NHE 90bp double-
stranded DNA (data not shown). EMSA was performed
to isolate the duplex DNA species containing the
G-quadruplex structure, which was 50-end
32P-labeled in
the G-rich and C-rich strands. Two bands (Figure 5B,
bands 1 and 2) were observed in both duplex DNA
samples (lanes 2 and 3) pre-incubated with 100mM KCl.
These bands were duplex DNA species, since they both
migrated diﬀerently to the single-stranded intramolecular
G-quadruplex species. The duplex DNA species contain-
ing the partially unwound region was less compact than
the linear duplex DNA and as expected showed slower
migration in EMSA. Thus band 1 corresponds to the
duplex DNA species containing the G-quadruplex struc-
ture, while band 2 corresponds to the fully linear duplex
DNA. By coincidence, this band migrates at the same
point as the presumed dimer intermolecular species from
the Pu60-mer. However, it cannot correspond to this
species since the NHE 60bp duplex DNA labeled on the
C-rich strand also gives this species. Bands 1 and 2 were
both extracted and subjected to DMS footprinting. The
full DMS cleavage pattern of band 2 conﬁrmed that it was
a linear duplex DNA (Figure 5C, lanes 3 and 4). A distinct
DMS protection pattern among three runs of guanines
(G3–G11, G16–G19 and G22–G25) was observed for the
G-rich strand of band 1 (Figure 5C, lanes 1 and 2).
Although it is not quite as well deﬁned as the DMS
footprinting patterns of the G-quadruplex species
obtained from single-stranded DNA (see Figure 4B,
Figure 6. Sequences (A) and comparative CD spectra (B) of the wild-
type sequence of the three 50-end runs of guanines and the G15/G21
double mutation sequences in the presence of 100mM KCl. Black
line=wild-type sequence PA-5W, red line=double G-to-T mutation
sequence PA-Mut1 and blue line=double G-to-A mutation sequence
PA-Mut2. All CD data were obtained with a 5mM strand concentra-
tion at 258C.
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corresponds very closely to that of the single-stranded
species associated with the 50-end product seen in the Taq
polymerase stop assay.
Mutation of guanines inthe loops leads todramatic
destabilization of thePDGF-A G-quadruplexes
A full mutational analysis of the three consecutive 50-runs
of guanines provided further insight into the sequence
requirements for stability of the NHEPDGF-A
G-quadruplexes. In accordance with the DMS footprint-
ing studies on the predicted mixture of loop isomers (see
Discussion Section), 12 sets of mutants, in which the
individual loop isomers were selected for, were compared
by the relative intensity of the CD at 285 nM (data not
shown). In all cases, the mutant sequences that were
predicted to form deﬁned loop isomers showed lower
stability. Surprisingly, all these guanine mutant isomers
showed a signiﬁcant decrease in parallel G-quadruplex
signals and an increase in antiparallel signals. This shows
that these mutants predominantly form antiparallel or
hybrid parallel/antiparallel G-quadruplex structures,
which is diﬀerent from the biologically relevant
NHEPDGF-A G-quadruplex. Among these guanine
mutant isomers, the most surprising results originated
from two dual mutants, PA-Mut1 and PA-Mut2
(Figure 6A). These two mutant oligomers were designed
to provide dual G-to-T or G-to-A base mutations at G15
and G21 in the core sequence of NHEPDGF-A. PA-Mut1
and PA-Mut2 were chosen because of the identiﬁed
cleavage sites shown in the DMS footprinting of the
PDGF-A Pu48 and the 60bp duplex of NHEPDGF-A
(Figures 4B and 5C). Therefore, G15 and G21 are not
required for G-tetrad formation, and it was predicted that
a mutation at these positions would not aﬀect the stability
or folding of the G-quadruplex in the NHEPDGF-A.
Unexpectedly, PA-Mut1 and PA-Mut2 both showed a
signiﬁcant decrease in ellipticity at 212 and 266nm and an
increase in the antiparallel shoulder absorption between
280 and 300nm, compared with the wild-type sequence of
the three consecutive 50-runs of guanines of NHEPDGF-A
(PA-5W) (Figure 6B). Substitution of other loop-position
guanines with other bases also resulted in the same
changes in CD.
Stabilization of theG-quadruplexes in theNHEPDGF-Awith
small molecules
One important goal of our studies is to identify
small molecules with the ability to speciﬁcally modulate
PDGF-A gene expression through stabilization or mod-
iﬁcation of the biologically relevant G-quadruplex
structures in the NHEPDGF-A. To gain further insight
into the selective action of G-quadruplex-interactive
agents with the NHEPDGF-A sequence, three well-
established G-quadruplex-interactive agents, TMPyP4,
telomestatin and Se2SAP (Figure 7A), were evaluated by
a Taq polymerase stop assay with a DNA template
containing the whole core sequence of the G-rich strand
of NHEPDGF-A. TMPyP2 (Figure 7A), a positional isomer
of TMPyP4 that lacks the ability to insert or stack into
the G-tetrad structures (52), served as the negative control
compound in our studies. Since there was a considerable
amount of 50-end stop products formed in the absence of
drugs and KCl (Figure 7B, lane 2), we used an elevated
primer extension temperature (608C) to partially destabi-
lize the arresting G-quadruplex structure and thereby
permit a larger window for drug stabilization of the
G-quadruplex structures. The pausing at the 50-end stop
product in the absence of G-quadruplex-interactive
ligands and KCl at a high temperature of 608C is another
indication that the G-quadruplex structure in the 50-end
product is more stable than other possible G-quadruplex
structures formed by the G-rich strand of NHEPDGF-A
(Figure 7B, lane 2). This suggests that the 50-end
G-quadruplex is the primary G-quadruplex structure
formed in NHEPDGF-A, corresponding to the one formed
in the NHE duplex DNA.
The results in Figure 7B (lanes 3–7) and Figure 7C (a)
show that TMPyP2 had a negligible eﬀect on the
formation of polymerase stop arrest products. When the
concentration of drugs was 0.05mM and lower (Figure 7B,
lanes 8 and 9), TMPyP4 signiﬁcantly increased stabiliza-
tion of the 50-end stop products in a concentration-
dependent manner, but telomestatin and Se2SAP only
marginally increased the formation of 50-end stop
products (lanes 13, 14, 19 and 20 in Figure 7B). In
contrast, when the concentration of all three drugs was
0.5mM and higher, decreased formation of the 50-end stop
products was observed for all three G-quadruplex-
interactive drugs, because of the accumulation of the
30-end stop product. TMPyP4 achieved the maximum
stabilizing eﬀect on the 50-end stop products at a
concentration of 0.05mM [Figure 7B, lane 9, and C (b)].
The Taq polymerase stop assay also showed that these
three G-quadruplex-interactive drugs induced formation
of the 30-end stop products at high drug concentrations
( 0.5mM). A concentration-dependent increase in stabi-
lization of the 30-end stop products was also observed for
all three drugs. However, telomestatin and Se2SAP were
more selective at stabilizing the 30-end stop product;
both achieved the best stabilizing eﬀect on the 30-end
G-quadruplex at a concentration of 1mM [Figure 7B, lane
21, and C (c and d)]. In addition, at drug concentrations of
1 and 2.5mM, TMPyP4 exhibited preferential binding
for duplex DNA over the G-quadruplex structures
(lanes 11 and 12 in Figure 7B).
TMPyP4 selectively inhibits the promoter activity ofthe
NHEPDGF-A
In light of our results demonstrating that the duplex DNA
of NHEPDGF-A can form a G-quadruplex structure, we
sought to determine if stabilization of this G-quadruplex
structure aﬀects PDGF-A transcription in vivo. Therefore,
we constructed pGL3-Basic derivative (pA361) in which
the human genomic DNA fragment containing the
proximal promoter region of PDGF-A (–218 to +142,
relative to the transcriptional start site) was inserted
upstream of the ﬁreﬂy luciferase reporter gene. When
transfected into MIA PaCa-2 human pancreatic cancer
cells, pA361 drove luciferase expression into these cells.
Nucleic Acids Research, 2007, Vol. 35, No. 22 7707Thus, the PDGF-A proximal promoter, which contains the
complete NHEPDGF-A core sequence, can drive transcrip-
tion in vivo. Furthermore, RT-PCR studies demonstrated
signiﬁcantly higher PDGF-A expression in MIA PaCa-2
cells than in the normal pancreatic cell line HPDE-6 (data
not shown).
Since TMPyP4at low concentrations selectively stabi-
lized the biologically relevant G-quadruplex structure
(the 50-end stop product) formed by duplex NHEPDGF-A
DNA in vitro, we directly assessed its speciﬁc biological
eﬀects on PDGF-A transcription. MIA PaCa-2 cells were
co-transfected with plasmids pA361 and pRL-TK as an
internal control and treated with varying concentrations
of TMPyP4 or TMPyP2. We measured the expression of
ﬁreﬂy luciferase relative to the renilla luciferase of pRL-
TK by dual luciferase assay, 24h after transfection. At all
concentrations used, TMPyP4 reduced the expression of
ﬁreﬂy luciferase activity by inhibiting the promoter
activity of NHEPDGF-A, whereas TMPyP2 had no
signiﬁcant eﬀect on the ﬁreﬂy luciferase activity
Figure 7. (A) Structures of the G-quadruplex-interactive compounds TMPyP4, telomestatin and Se2SAP, and the control compound TMPyP2.
(B) The Taq polymerase stop assay was used to compare the stabilization of the NHEPDGF-A G-quadruplex by TMPyP2 (lanes 3–7), TMPyP4
(lanes 8–12), telomestatin (lanes 13–17) and Se2SAP (lanes 18–22) by using increasing concentrations of drugs (0.01, 0.05, 0.5, 1 and 2.5mM) at 608C.
Lane 1 is control, and lane 2 is without drug. (C) The ratios of the major arrest products of each sample to the total product were plotted against
drug concentrations.
7708 Nucleic Acids Research, 2007, Vol. 35, No. 22(Figure 8). We found that 10mM TMPyP4 could
reduce the expression of ﬁreﬂy luciferase to  50% of the
control, indicating that the stabilization of the
G-quadruplex has a strong repression eﬀect on promoter
activity of NHEPDGF-A. This data suggests that the stable
G-quadruplex structure formed locally in the human
PDGF-A promoter at NHE is likely to behave as a
transcription repression in vivo.
DISCUSSION
Up-regulation of PDGF activity has been implicated in
the pathogenesis of a number of serious diseases, including
cancer, as well as other disorders characterized by
excessive cell growth, such as atherosclerosis and various
ﬁbrotic conditions (3,5,6), as described in the Introduction
Section. One strategy to block PDGF signaling pathways
is to target the PDGF receptors. Employment of this
strategy led to the discovery of selective PDGF antago-
nists (5,53,54). For example, the PDGF receptor kinase
inhibitor STI-571 (Gleevec) has been approved for clinical
use for the treatment of certain tumors (54–56). Because
the PDGF-A polypeptide is short in length, it has not been
thought of as a druggable anticancer target. However,
another viable strategy for targeting PDGF signaling
pathways in tumors is to decrease PDGF-A expression by
inhibiting its promoter activity. Transcription of PDGF-A
is under the strict control of NHEPDGF-A in the promoter.
The unwound paranemic NHEPDGF-A structure plays an
important role in regulating transcription factors that bind
to the PDGF-A promoter. The G-rich strand
of NHEPDGF-A, which contains ﬁve G-tracts with each
G-tract separated from the neighboring G-tract by a single
intervening base, is anticipated to form G-quadruplex
structures under physiological conditions. Therefore, the
NHEPDGF-A G-quadruplex structure is potentially
involved in transcriptional control of PDGF-A expres-
sion, perhaps as the silencer element. Consequently, the
search for compounds that have selectivity for binding to
the NHEPDGF-A G-quadruplex and that inhibit PDGF-A
gene expression might well be valuable in the treatment of
some cancers and other disorders, as described earlier.
In the present study, we demonstrate that the G-rich
strand of NHEPDGF-A, located within the proximal
promoter region of PDGF-A, is able to form two stable
intramolecular parallel G-quadruplex structures (30-end
and 50-end G-quadruplexes) that are potentially involved
in transcriptional regulation. The formation of these
G-quadruplex structures is K
+-dependent. The DMS
footprinting patterns of the G-quadruplexes formed by
PDGF-A Pu48 and Pu60 imply that these structures
must contain at least four G-tetrads, and this is supported
by the CD data in Figure 2A, in which the molar ellipticity
is greater for the PDGF-A G-quadruplex than for the
c-Myc G-quadruplex. Signiﬁcantly, an intramolecular
G-quadruplex that has a similar folding pattern to the
50-end G-quadruplex found in single-stranded DNA of
NHEPDGF-A can be formed within the duplex DNA of
NHEPDGF-A. In light of the protocol for formation of the
duplex containing the G-quadruplex, the G-quadruplex
obtained within the duplex DNA of NHEPDGF-A probably
Figure 7. Continued.
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Thus, the species formed during the annealing is a result
of hybridization of the single-stranded G-rich strand
already containing the G-quadruplex with the single-
stranded C-rich strand. This is unlikely to be the same
mechanism for the formation of the G-quadruplex
structure within the duplex DNA in in vivo situations
where superhelicity is involved (see subsequently).
Nevertheless, this is the ﬁrst time that we have been
able to isolate the duplex DNA containing a
G-quadruplex structure in vitro. This unique structure is
likely to represent the dominant biologically relevant
G-quadruplex structure formed in the PDGF-A promoter.
It has been proposed that superhelicity of genomic DNA
may play an important role in determining the presence of
such an interconversion (57,58). The functional analysis of
the PDGF-A promoter revealed that the NHEPDGF-A
adopted a non-B-DNA conformation and was hypersen-
sitive to the S1 nuclease in the supercoiled plasmids
(13–16). This provides further evidence that the formation
of a G-quadruplex in the NHEPDGF-A can compete
with the superhelical duplex conformation in vivo. The
implication of the formation of a stable G-quadruplex
in duplex DNA is that the C-rich strand forms a single-
stranded DNA loop, which may be in equilibrium with an
i-motif structure.
The folding pattern of the biologically relevant
G-quadruplex structure formed by the three consecutive
G-tracts (G1–G25) at the 50-end of NHEPDGF-A duplex
DNA most likely represents a mixture of diﬀerent loop
isomers. Of particular interest, the 13-mer G-tract
(G1–G13) must provide the two runs of guanines at the
50-end. The ﬂanking regions of NHEPDGF-A are also made
up of polypurine and polypyrimidine elements, which
may have a signiﬁcant impact on the propensity to form
the G-quadruplex in the G-rich strand of NHEPDGF-A
double-stranded DNA. The overall folding patterns of
the parallel G-quadruplex structure in NHEPDGF-A
duplex DNA has been deﬁned by its characteristic CD
spectra, which demonstrates that it has a unique
double-chain reversal structure. Previously, examples of
G-quadruplexes consisting of double-chain reversals in
promoter regions have been conﬁned to three tetrads with
a single base in the internal loop. This is the ﬁrst example
of a G-quadruplex with four tetrads and a two-base
internal loop. The DMS footprinting pattern of the
G-quadruplex in NHEPDGF-A duplex DNA reveals that
the 30-face of this G-quadruplex structure has two runs of
four guanines, which are separated by a two-base (CG)
internal loop. A molecular model of the four G-tetrads in
the NHEPDGF-A G-quadruplex structure shows that a
two-base internal loop is the minimum required to bridge
two runs of four guanines (Figure 9A). The opposite
50-face of this G-quadruplex structure is constructed from
the run of 13 contiguous guanines, in which the DMS
footprinting pattern predicts a mixture of at least four
double-chain reversal loop isomers (Figure 9B). Loop
isomers ‘a’, ‘b’, and ‘c’ in Figure 9B have a two-base
internal loop on the 50-face dictated by the demonstrated
DMS cleavages of G11, G12 and G13 (‘a’ isomer),
G12 and G13 (‘b’ isomer) and G1 and G2 (‘c’ isomer) in
the core sequence of NHEPDGF-A (see Figure 4B). Finally,
the cleavage of G5, G6 and G7 predicts loop isomer ‘d’.
By analogy with the c-Myc parallel G-quadruplex
structure, in which the double-chain reversal loops on
the opposite face are suﬃcient to stabilize a third
intervening loop size of six bases, the double-chain
reversals in the NHEPDGF-A G-quadruplex can stabilize
a third internal loop of up to ﬁve bases (as predicted in
loop isomer ‘a’ in Figure 9B) (38). Two views of a
molecular model of loop isomer ‘a’ having the predicted
folding pattern are shown in Figure 9A.
A surprising ﬁnding illustrated by the CD results shown
in Figure 6B for two dual mutant oligomers is that base
changes, even in potential loop positions, result in
destabilization and apparent dramatic changes in the
folding patterns. This is in contrast to the c-Myc
G-quadruplex, where elimination of the redundancy in
loop isomers by judicial G-to-T mutations does not
dramatically change the stability or folding patterns
of the parallel-stranded G-quadruplex (38). The eﬀects
of G-to-N mutations in the NHEPDGF-A G-quadruplexes
are not limited to the run of 13 contiguous guanines, but
also occur when the 30 terminal guanines in the two runs of
5 guanines (G15 and G21) are mutated to thymines or
adenines. On the basis of DMS cleavage results, these
guanines are predicted to be predominantly in the loops,
implying that the dynamic equilibrium between diﬀerent
loop isomers is an important feature of both stability and
formation of the parallel-stranded species. This phenom-
enon may be uniquely linked to the 13 contiguous
guanines in this promoter sequence.
An important aim of our research program is to identify
small molecules that can selectively modulate PDGF-A
transcription by stabilizing or modifying the unique
G-quadruplex structures formed by NHEPDGF-A.
Therefore, we examined the aﬃnities of three well-
known G-quadruplex-interactive drugs (TMPyP4,
Se2SAP and telomestatin) for the NHEPDGF-A
G-quadruplex. The results of our Taq polymerase stop
assays revealed that these three drugs preferentially
Figure 8. Dual luciferase assay to determine the eﬀect of TMPyP4 and
TMPyP2 on the transcriptional activity of PDGF-A basal promoter
containing the NHE. The comparative ﬁreﬂy luciferase expressions
(ﬁreﬂy/renilla) of TMPyP2 and TMPyP4 are shown in the histograms.
The values are the average of three independent experiments. Error
bars are  SE.
7710 Nucleic Acids Research, 2007, Vol. 35, No. 22interact with and stabilize the 50-end NHEPDGF-A
G-quadruplex, which has a similar folding pattern to the
biological G-quadruplexes formed in the NHEPDGF-A
duplex DNA at low concentrations. TMPyP4 exhibited
stronger selectivity than either Se2SAP or telomestatin
for stabilization of the 50-end stop product. Thus,
TMPyP4 appeared to be an ideal candidate for modulat-
ing PDGF-A transcription. Our data conﬁrms that, in
cells, TMPyP4 can speciﬁcally downregulate PDGF-A
promoter activity by interacting with the NHEPDGF-A
G-quadruplex. Because TMPyP4, and not TMPyP2,
inhibits PDGF-A proximal promoter activity, this is
strong evidence that G-quadruplexes exist in vivo and
that NHEPDGF-A G-quadruplex structures act as tran-
scriptional silencers for PDGF-A.
Finally, the relationship of the 50SHS and intron SHS
elements to the dynamic equilibrium of the G-quadruplex
and associated C-strand structures remains to be deter-
mined. The complementarity of the 50SHS and the 50-end
of the intron SHS is suggestive of the interaction of these
elements. Experiments addressing this question are in
progress.
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